The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHelios Underw Regulatory News (HUW)

Share Price Information for Helios Underw (HUW)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 165.00
Bid: 160.00
Ask: 170.00
Change: -3.50 (-2.08%)
Spread: 10.00 (6.25%)
Open: 168.50
High: 168.50
Low: 162.00
Prev. Close: 168.50
HUW Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

4 Apr 2023 07:00

RNS Number : 2135V
Helios Underwriting Plc
04 April 2023
 

4th April 2023

 

 

Helios Underwriting plc

("Helios" or the "Company")

 

Directorship Change

 

Appointment of Martin Reith as Chief Executive

 

Helios, the unique investment vehicle that acquires and consolidates underwriting capacity at Lloyd's, is delighted to announce the appointment of Martin Reith as an Executive Director of the Company and as Chief Executive Officer ('CEO') with immediate effect. Nigel Hanbury will remain on the Board as Executive Deputy Chairman, so that the Board can continue to benefit from his leadership and his extensive knowledge of Lloyd's.

 

Martin Reith has nearly 40 years' experience across underwriting, management and leadership. Prior to joining Helios as a Non-Executive Director in 2021, he held board positions at Neon Underwriting Limited, as CEO from 2015 to 2019 and then assumed a non-executive role until 2020. For the last 12 months, Martin has been heavily involved in advising the Board on the curation of the Helios capacity portfolio.

 

Martin was the founder and CEO of Ascot Underwriting Limited, which he established in 2001 with the support and backing of AIG. Under his leadership, Ascot became one of the largest and top-performing businesses in Lloyd's with a network of overseas offices. In 2009, Martin stepped down as CEO and served as a non-executive on Ascot's board from 2009 to 2011. Prior to Ascot, he served as CEO of XL Capital's Insurance Operations in London. He is the founder of The Nick Kilhams Foundation, a suicide prevention charity focused on helping city professionals. He has also been a member of the board of directors at AmWINS Group Inc. and has previously served as a director to Securis Investment Partners LLP, an ILS fund based in London, on their various boards. He is currently non-executive chair at Artificial Labs and a board member of Prospero Re, the reinsurance vehicle of Bermuda headquartered ILS fund and investment manager Resolute Global Partners Ltd, a 17.3% shareholder of the Company.

 

Commenting on his appointment, Martin Reith said:

"Helios is an extraordinary business that has grown significantly in recent years and is seen as the benchmark for private capital in the Lloyd's market. I see exciting opportunities for further shareholder value creation, specifically by repositioning the earnings stream into a combination of underwriting returns, fees and commissions to support further profitable growth. I look forward to setting out my strategy in detail in due course."

 

 

Michael Cunningham, Non-Executive Chairman of Helios Underwriting, commented:

"We are delighted by Martin's elevation to CEO. His proven experience in driving growth strategies and creating significant shareholder value means that he is perfectly positioned to lead Helios on to its next stage of evolution.

 

"We are also very pleased that we will continue to benefit from Nigel's experience and expertise. In his decade as Chief Executive he has led Helios from strength to strength through strategically targeted acquisition activity and organic growth.

 

"With a plethora of opportunities open to us to take advantage of the current Lloyd's market conditions to drive further growth, we look to the future with confidence."

 

For further information please contact:

 

Helios Underwriting plc

Martin Reith - Chief Executive +44(0)7720 292 505

Nigel Hanbury - Executive Deputy Chairman +44 (0)7787 530 404

Arthur Manners - Chief Financial Officer +44 (0)7754 965 917

 

Shore Capital (Nomad and Broker)

Robert Finlay +44 (0)20 7601 6100

David Coaten

 

Buchanan (PR)

Helen Tarbet / Henry Wilson / George Beale +44 (0)7872 604 453

+44 (0)20 7466 5111

 

About Helios

Helios provides a limited liability direct investment into the Lloyd's insurance market and is quoted on the London Stock Exchange's AIM market (ticker: HUW). Helios trades within the Lloyd's insurance market writing approximately £297m of capacity for the 2023 account. The portfolio provides a good spread of business being concentrated in property & casualty insurance and reinsurance. For further information please visit www.huwplc.com.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOADZGGDKFLGFZM
Date   Source Headline
23rd Dec 20137:00 amRNSAcquisition of Two Corporate Members
12th Dec 201311:26 amRNSHolding(s) in Company
6th Dec 20135:51 pmRNSResult of General Meeting
20th Nov 20137:00 amRNSProposed Change of Name
13th Nov 20137:00 amRNSCompletion of Acquisition
17th Oct 20137:00 amRNSAcquisition of Corporate Member
15th Oct 20137:00 amRNSReinsurance Renewal and Acquisitions
26th Sep 20137:00 amRNSHalf Yearly Report
26th Jul 201311:21 amRNSReinsurance Agreement
9th Jul 20137:00 amRNSDirectorate Change
27th Jun 20134:01 pmRNSResult of AGM
24th Jun 201310:27 amRNSDirectorate Change
14th Jun 20135:56 pmRNSHolding(s) in Company
4th Jun 20135:28 pmRNSAnnual Report and Notice of AGM
29th May 20137:00 amRNSFinal Results
23rd Apr 20138:18 amRNSHolding(s) in Company
6th Feb 20137:00 amRNSInvestment Strategy
1st Feb 20135:11 pmRNSHolding(s) in Company
21st Dec 20127:00 amRNSAcquisition of Corporate Member
26th Nov 20127:00 amRNSAcquisition of Corporate Member
16th Oct 20125:24 pmRNSHolding(s) in Company
10th Oct 201211:51 amRNSHolding(s) in Company
2nd Oct 20127:00 amRNSAcquisition & Total Voting Rights
28th Sep 20127:00 amRNSHalf Yearly Report
21st Jun 20124:41 pmRNSAGM Statement
29th May 20129:25 amRNSAnnual Report and Notice of AGM
23rd May 20127:00 amRNSFinal Results
28th Sep 20117:00 amRNSHalf Yearly Report
24th May 20119:27 amRNSPosting of Annual Report
23rd May 20117:00 amRNSFinal Results
6th Jan 20116:25 pmRNSDirector/PDMR Shareholding
10th Dec 20102:42 pmRNSDirector/PDMR Shareholding
6th Dec 20104:33 pmRNSDirector/PDMR Shareholding
30th Sep 20107:00 amRNSHalf Yearly Report
5th Aug 20101:00 pmRNSAcquisition of corporate member
18th Jun 20109:40 amRNSResult of AGM
26th May 20101:16 pmRNSAnnual Report and Notice of AGM
21st May 20101:25 pmRNSDirector/PDMR Shareholding
21st May 20107:00 amRNSFinal Results
29th Sep 20097:00 amRNSHalf Yearly Report
19th Jun 20097:00 amRNSResult of AGM
28th May 200912:15 pmRNSAnnual Report and Notice of AGM
18th May 20097:00 amRNSFinal Results
16th Feb 20099:05 amRNSAcquisition
28th Oct 20083:57 pmRNSDirector Declaration
25th Sep 20087:00 amRNSInterim Results
17th Jun 20087:00 amRNSAvailability of accounts
28th Mar 20087:01 amRNSFinal Results
1st Feb 200810:04 amRNSAcquisition
30th Nov 20074:16 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.